Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non–small cell lung, prostate, and breast cancers
Overview of attention for article published in JNCI: Journal of the National Cancer Institute, September 2024
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (74th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 10 Mendeley